---
created: 2025-04-13
updated: 2025-04-13T10:53
id: q`*rY;fMSu
specialty: cardio
specialty_id: 316
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/firstaid::07-cardiovascular::05-pharm::17-ivabradine
  - "source/ak-step1-v11:": 
  - source/ome-banner::basic-science::09-cardiac
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::10-cardiac::22-ivabradine
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::06-cardio::ivabradine
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::02-cardio-&-renal::fa-cardio
  - source/ak-step1-v11::$ankingupdates::$errata::v11
  - source/ak-step1-v11::^other::^expn
  - source/ak-step1-v11::^other::^highyield::4-loweryield
  - source/ak-step1-v11::^systems::cardio::pharmacology
  - "source/ak-step2-v11:": 
  - theme/b&b::01-cardiology::pharm::cvs-pharm-2"
type: flashcard
---

# Question
Ivabradine is contraindicated in **sick sinus syndrome::rhythm problem**, characterized on ECG by delayed P wave or the absence of a P wave with the QRS complex formed by a junctional escape beat

---

# Answer
- malfunction of SA node; tachycardia-bradycardia syndrome is most common variant of sick sinus syndrome (arrhythmia alternates between fast and slow beats) - drugs to control tachyarrhythmias are contraindicated, because this may swing patient into full bradycardia (throw in a pacemaker first before you start drug therapy)